JPH032875B2 - - Google Patents

Info

Publication number
JPH032875B2
JPH032875B2 JP31768789A JP31768789A JPH032875B2 JP H032875 B2 JPH032875 B2 JP H032875B2 JP 31768789 A JP31768789 A JP 31768789A JP 31768789 A JP31768789 A JP 31768789A JP H032875 B2 JPH032875 B2 JP H032875B2
Authority
JP
Japan
Prior art keywords
compound
coch
epipodophyllotoxin
demethyl
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP31768789A
Other languages
Japanese (ja)
Other versions
JPH02191294A (en
Inventor
Katsuhiko Kurabayashi
Hidefumi Kinoshita
Hitoshi Saito
Toshio Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Priority to JP31768789A priority Critical patent/JPH02191294A/en
Publication of JPH02191294A publication Critical patent/JPH02191294A/en
Publication of JPH032875B2 publication Critical patent/JPH032875B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、制癌剤として有用な物質を収率よく
製造するための原料に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a raw material for producing a substance useful as an anticancer agent in good yield.

(従来の技術) 制癌剤として有用な化合物である、4′−デメチ
ル−エピポドフイロトキシン−β−D−エチリデ
ングリコシドの製造法としては、特公昭45−
38258号および特公昭46−37837号が知られてい
る。
(Prior art) As a method for producing 4'-demethyl-epipodophyllotoxin-β-D-ethylidene glycoside, which is a compound useful as an anticancer agent,
No. 38258 and Special Publication No. 46-37837 are known.

(発明が解決しようとする課題) しかしながらこれらの方法においてはアグリコ
ンの保護基と糖のそれとが異なるため、それらの
除去には2工程を要する。即ちアグリコンの4
位′の保護基であるベンジルオキシカルボニル基
を除去するのにパラジウム−炭素を触媒として水
素添加分解を行い、糖の保護基であるアセチル基
またはホルミル基の除去に酢酸亜鉛を用いてい
る。特に糖の保護基の除去には高温かつ長時間を
必要とし、例えば、20〜30時間反応させても反応
は完結せず、更に反応させると副生物が増加する
ため収率が低下し工業的製法としては好ましくな
い。
(Problems to be Solved by the Invention) However, in these methods, since the protecting group of the aglycone and that of the sugar are different, two steps are required for their removal. That is, aglycone 4
Hydrogenolysis is carried out using palladium-carbon as a catalyst to remove the benzyloxycarbonyl group which is the protective group at position ', and zinc acetate is used to remove the acetyl or formyl group which is the sugar protective group. In particular, the removal of sugar protecting groups requires high temperatures and long periods of time; for example, the reaction is not completed even after 20 to 30 hours, and further reaction increases by-products, resulting in lower yields and lower industrial performance. This is not a good manufacturing method.

(課題を解決するための手段) そこで本発明者らは上記欠点を克服するために
種々検討した結果、特定の原料化合物とアミンお
よび/またはアンモニアを0゜〜室温で数時間反応
させることにより、アグリコンの4′位および糖の
2位、3位の保護基が一挙にしかも安全に除去で
き、高純度の4′−デメチル−エピポドフイロトキ
シン−β−D−エチリデングルコシドを高収率で
得ることができることを見出し本発明を完成し
た。
(Means for Solving the Problems) Therefore, the present inventors conducted various studies to overcome the above-mentioned drawbacks, and found that by reacting a specific raw material compound with an amine and/or ammonia at 0° to room temperature for several hours, Protecting groups at the 4'-position of the aglycone and the 2- and 3-positions of the sugar can be removed all at once and safely, allowing highly purified 4'-demethyl-epipodophyllotoxin-β-D-ethylidene glucoside to be produced in high yield. The present invention was completed based on the discovery that the present invention can be obtained.

即ち、本発明は4′−ハロゲノアセチル−4′−デ
メチル−エピポドフイロトキシン−β−D−2,
3−ジ−O−ハロゲノアセチル−4,6−O−エ
チリデングルコシド()に関し、これをアミン
および/またはアンモニアと反応させることによ
りハロゲノアセチル基を除去し4′−デメチル−エ
ピポドフイロトキシン−β−D−エチリデングル
コシド()とすることが出来る。
That is, the present invention provides 4'-halogenoacetyl-4'-demethyl-epipodophyllotoxin-β-D-2,
Regarding 3-di-O-halogenoacetyl-4,6-O-ethylidene glucoside (), the halogenoacetyl group is removed by reacting it with an amine and/or ammonia to produce 4'-demethyl-epipodophyllotoxin- β-D-ethylidene glucoside ().

〔式中、Rは−COCH2X(式中Xはハロゲンを
示す)で表わされるハロゲノアセチル基を示す〕
上記式()で示される化合物はVP16−213と呼
ばれ、抗腫瘍活性を示す制癌剤として有用な物質
である。
[In the formula, R represents a halogenoacetyl group represented by -COCH 2 X (in the formula, X represents a halogen)]
The compound represented by the above formula () is called VP16-213, and is a substance useful as an anticancer agent that exhibits antitumor activity.

本発明においてアグリコンの4′位および糖の2
位、3位のハロゲノアセチル基Rは同一であつて
もよく、又、異なつていてもよい。Xのハロゲン
としては塩素、臭素が挙げられる。
In the present invention, the 4′ position of the aglycone and the 2′ position of the sugar
The halogenoacetyl groups R at the positions R and 3 may be the same or different. Examples of the halogen for X include chlorine and bromine.

化合物()と反応させるアミンとしては、メ
チルアミン、エチルアミン、n−プロピルアミ
ン、n−ブチルアミンなどの脂肪族一級アミン、
ジメチルアミン、ジエチルアミン、ジ−n−プロ
ピルアミン、ジ−n−ブチルアミンなどの脂肪族
二級アミン、ピロリジン、ピペリジン、モルホリ
ンなどの環状アミンおよびエチレンジアミンなど
の脂肪族ジアミン等が挙げられる。これらのアミ
ンおよび/またはアンモニアを使用する場合、そ
のまま反応系に加えてもよいのは当然であるが、
例えばピリジン、トリエチルアミンなどの塩基共
存下に、アミンおよび/またはアンモニアの酢酸
塩、塩酸塩などを加えて反応系内で遊離のアミン
および/またはアンモニアを調製して反応させて
もよい。その使用量は化合物()に対して3〜
10モル倍が適当である。
The amines to be reacted with the compound () include aliphatic primary amines such as methylamine, ethylamine, n-propylamine, and n-butylamine;
Examples include aliphatic secondary amines such as dimethylamine, diethylamine, di-n-propylamine, and di-n-butylamine, cyclic amines such as pyrrolidine, piperidine, and morpholine, and aliphatic diamines such as ethylenediamine. When using these amines and/or ammonia, it is natural that they may be added to the reaction system as they are, but
For example, in the presence of a base such as pyridine or triethylamine, an acetate or hydrochloride of an amine and/or ammonia may be added to prepare a free amine and/or ammonia in the reaction system, and the reaction may be performed. The amount used is 3 to 3 for the compound ()
A ratio of 10 moles is appropriate.

反応温度はアミンの種類によつて変りうるが−
10〜100℃が好ましく、特に0〜70℃が適してい
る。反応に要する時間はアミンの種類、反応温度
によつて異なるが、通常0.5〜5時間である。
The reaction temperature can vary depending on the type of amine.
A temperature of 10 to 100°C is preferred, and a temperature of 0 to 70°C is particularly suitable. The time required for the reaction varies depending on the type of amine and the reaction temperature, but is usually 0.5 to 5 hours.

使用する溶媒としては、反応に悪影響を与えな
いものであれば特に制限はないが、例えば、クロ
ロホルム、塩化エチレン、メタノール、エタノー
ル、ピリジンなどが挙げられる。
The solvent to be used is not particularly limited as long as it does not adversely affect the reaction, and examples thereof include chloroform, ethylene chloride, methanol, ethanol, and pyridine.

この方法によれば、ハロゲノアセチル基Rの除
去が短時間かつ温和な条件下で容易に行われ、化
合物()から化合物()を高収率で得ること
ができる。その為、反応終了後の精製も容易であ
り、例えば、反応液を水洗し、簡単な再結晶を行
うだけで純粋な化合物()が得られるので工業
的製法として極めて有利な方法である。
According to this method, the halogenoacetyl group R can be easily removed in a short time and under mild conditions, and compound () can be obtained from compound () in high yield. Therefore, purification after the completion of the reaction is easy; for example, pure compound (2) can be obtained by simply washing the reaction solution with water and performing simple recrystallization, making this method extremely advantageous as an industrial production method.

本発明の式()の化合物は、植物
Podophyllumemodi Wallが生産する抗腫瘍活性
物質ポドフイロトキシンから得られる4′−デメチ
ル−エピポドフイロトキシン()(特公昭43−
6469号公報参照)を原料として、例えば次の反応
経録を経て合成される。
The compound of formula () of the present invention
4′-demethyl-epipodophyllotoxin () obtained from podophyllotoxin, an antitumor active substance produced by Podophyllumemodi Wall
6469) as a raw material, it is synthesized, for example, through the following reaction history.

〔式中Rは前記と同じ〕 即ち、4′−デメチル−エピポドフイロトキシン
()に不活性溶媒中でハロゲノアセチルクロリ
ドを反応させて得られる4′−ハロゲノアセチル−
4′−デメチル−エピポドフイロトキシン()を
不活性溶媒中、三弗化硼素エチルエーテラートの
存在下、0℃より低い温度で4,6−O−エチリ
デン−2,3−ジ−O−ハロゲノアセチル−β−
D−グルコピラノース()と縮合させることに
より化合物()が得られる。ここで化合物
()は新規化合物であり、4,6−エチリデン
−1−O−ベンジルオキシカルボニル−β−D−
グルコピラノース()を原料として、例えば次
の反応経路を経て合成される。
[In the formula, R is the same as above] That is, 4'-halogenoacetyl- obtained by reacting 4'-demethyl-epipodophyllotoxin () with halogenoacetyl chloride in an inert solvent.
4'-Demethyl-epipodophyllotoxin (2018) was dissolved in 4,6-O-ethylidene-2,3-di-O in an inert solvent in the presence of boron trifluoride ethyl etherate at a temperature below 0°C. -halogenoacetyl-β-
Compound () is obtained by condensation with D-glucopyranose (). Here, compound () is a new compound, 4,6-ethylidene-1-O-benzyloxycarbonyl-β-D-
It is synthesized using glucopyranose () as a raw material, for example, through the following reaction route.

〔式中Rは前記と同じ〕 即ち、4,6−O−エチリデン−1−O−ベン
ジルオキシカルボニル−β−D−グルコピラノー
ス()を不活性溶媒中、ハロゲノアセチルクロ
リドと反応させて得られる4,6−O−エチリデ
ン−1−O−ベンジルオキシカルボニル−2,3
−ジ−O−ハロゲノアセチル−β−D−グルコピ
ラノース()を水素添加分解することにより化
合物()が得られる。
[In the formula, R is the same as above] That is, obtained by reacting 4,6-O-ethylidene-1-O-benzyloxycarbonyl-β-D-glucopyranose () with halogenoacetyl chloride in an inert solvent. 4,6-O-ethylidene-1-O-benzyloxycarbonyl-2,3
Compound () is obtained by hydrogenolyzing -di-O-halogenoacetyl-β-D-glucopyranose ().

(実施例) 以下に実施例を挙げて本発明を具体的に説明す
る。
(Example) The present invention will be specifically described below with reference to Examples.

実施例 1 4′−デメチル−エピポドフイロトキシン−β−
D−エチリデングルコシド()の製法 4′−クロロアセチル−4′−デメチル−エピポド
フイロトキシン−β−D−2,3−ジ−O−クロ
ロアセチル−4,6−O−エチリデングルコシド
()(R=−COCH2Cl)8,2gをピリジン50
mlに溶解し0℃に冷却する。70%エチルアミン
4.5gを滴下し0℃で1時間撹拌する。反応終了
後クロロホルム200mlを加えて2N塩酸で中和し水
洗後無水硫酸ナトリウムで乾燥する。溶媒を減圧
下留去して得られた粗結晶をクロロホルムから再
結晶して結晶4.9gを得た。(収率83.1%) ここで得た結晶のTCLのRf値(シリカゲル、
展開溶媒クロロホルム:メタノール=9:1)、
IR、NMR、旋光度は特公昭46−37837号の方法
により得られた物質のそれと同一であつた。
Example 1 4'-demethyl-epipodophyllotoxin-β-
Process for producing D-ethylidene glucoside () 4'-chloroacetyl-4'-demethyl-epipodophyllotoxin-β-D-2,3-di-O-chloroacetyl-4,6-O-ethylidene glucoside () (R=-COCH 2 Cl) 8.2g pyridine 50
ml and cooled to 0°C. 70% ethylamine
Add 4.5g dropwise and stir at 0°C for 1 hour. After the reaction is complete, add 200 ml of chloroform, neutralize with 2N hydrochloric acid, wash with water, and dry over anhydrous sodium sulfate. The crude crystals obtained by distilling off the solvent under reduced pressure were recrystallized from chloroform to obtain 4.9 g of crystals. (Yield 83.1%) Rf value of TCL of the crystal obtained here (silica gel,
Developing solvent chloroform:methanol=9:1),
IR, NMR, and optical rotation were the same as those of the material obtained by the method of Japanese Patent Publication No. 46-37837.

m.p.259〜262℃,Rf=0.44 実施例 2 4′−デメチル−エピポドフイロトキシン−β−
D−エチリデングルコシド()の製法 実施例1においてエチルアミンの代りにピロリ
ジン4.5gを用いて実施例1と同様にして反応を
行つたところ、化合物()4.6gを得た。(収率
78.0%) 実施例 3 4′−デメチル−エピポドフイロトキシン−β−
D−エチリデングルコシド()の製法 実施例1においてエチルアミンの代りに98%エ
チレンジアミン2.0gを用いて実施例1と同様に
して反応を行つたところ、化合物()4.9gを
得た。(収率83.1%) 実施例 4 4′−デメチル−エピポドフイロトキシン−β−
D−エチリデングルコシド()の製法 化合物()(R=−COCH2Cl)8.2gをクロ
ロホルム150mlとメタノール50mlの混合溶媒に溶
解し、ジエチルアミン6.6gを加えて室温で4時
間撹拌する。反応終了後実施例1と同様に処理し
て化合物()3.6gを得た。(収率61.0%) 実施例 5 4′−デメチル−エピポドフイロトキシン−β−
D−エチリデングルコシド()の製法 化合物()(R=−COCH2Cl)8.2gをメタ
ノール150mlに懸濁し、ピリジン10mlおよび酢酸
アンモニウム5.0gを加えて1時間還流する。メ
タノールを減圧下留去した後実施例1と同様に処
理して化合物()4.5gを得た。(収率76.3%) 実施例 6 4′−デメチル−エピポドフイロトキシン−β−
D−エチリデングルコシド()の製法 化合物()(R=−COCH2Cl)8.2gをクロ
ロホルム150mlとメタノール50mlの混合溶媒に溶
解し、トリエチルアミン10mlおよび塩化アンモニ
ウム3.5gを加えて室温で4時間撹拌する。反応
終了後実施例1と同様に処理して化合物()
4.9gを得た。(収率83.1%) 実施例 7 4′−デメチル−エピポドフイロトキシン−β−
D−エチリデングルコシド()の製法 実施例6において化合物()(R=−
COCH2Cl)の代りに4′−ブロモアセチル−4′−デ
メチル−エピポドフイロトキシン−β−D−2,
3−ジ−O−ブロモアセチル−4,6−O−エチ
リデングルコシド()(R=−COCH2Br)9.5
gを用いて実施例6と同様にして反応を行つたと
ころ、化合物()4.8gを得た。(収率81.8%) 実施例 A 4′−クロロアセチル−4′−デメチル−エピポド
フイロトキシン−β−D−2,3−ジ−O−ク
ロロアセチル−4,6−O−エチリデングルコ
シド()(R=−COCH2Cl)の製法 (a) 4′−クロロアセチル−4′−デメチル−エピポ
ドフイロトキシン()(R=−COCH2Cl)の
製法 4′−デメチル−エピポドフイロトキシン()
40.0gを無水塩化エチレン750mlに懸濁させ、無
水ピリジン11.9gを加えた後−20℃に冷却する。
この液に95%塩化クロロアセチル15.4gを1.5時
間を要して滴下し、更に0.5時間撹拌する。反応
終了後、反応液を水洗し有機層を無水硫酸ナトリ
ウムで乾燥する。溶媒を減圧下留去して得られた
粗生成物をメタノールから再結晶して化合物
()(R=−COCH2Cl)43.4gを得た。(収率
91.1%) m.p.238〜240℃ IRνKBr nax3550,1783,1765(sh),1483,1230,
1130cm-1 (b) 4,6−O−エチリデン−1−O−ベンジル
オキシカルボニル−2,3−ジ−O−クロロア
セチル−β−D−グルコピラノース()(R
=−COCH2Cl)の製法 4,6−O−エチリデン−1−O−ベンジルオ
キシカルボニル−β−D−グルコピラノース
()51.0gを無水クロロホルム500mlに懸濁さ
せ、無水ピリジン35.6gを加えて0℃に冷却す
る。この液に95%塩化クロロアセチル42.8gを1
時間を要して滴下した後、室温で0.5時間撹拌す
る。反応終了後反応液を水洗し有機層を無水硫酸
ナトリウムで乾燥する。溶媒を減圧下留去して得
られた粗生成物をイソプロピルエーテルから再結
晶して化合物()(R=−COCH2Cl)66.6gを
得た。(収率90.1%) m.p.130〜131℃ IRνKBr nax1765,1255,1098,700cm-1 (c) 4,6−O−エチリデン−2,3−ジーO−
クロロアセチル−β−D−グルコピラノース
()(R=−COCH2Cl)の製法 化合物()(R=−COCH2Cl)49.3gを乾燥
アセトン500mlに溶解し、10%パラジウム−炭素
10gを加えて−10〜15℃で常圧で水素添加を行
う。反応終了後触媒を別し乾燥アセトン100ml
で洗浄した後、溶媒を浴温30℃で減圧濃縮し、残
渣を高真空下30℃で乾燥して化合物()(R=
−COCH2Cl)35.6gを白い泡状物として得た。
(収率99.2%) IRνCHCl3 nax3600,1765,1282,1130,1095cm-1 (d) 4′−クロロアセチル−4′−デメチル−エピポ
ドフイロトキシン−β−D−2,3−ジ−O−
クロロアセチル−4,6−O−エチリデングル
コシド()(R=−COCH2Cl)の製法 化合物()(R=−COCH2Cl)11.9gを無水
塩化エチレン150mlに溶解し、次いで化合物()
(R=−COCH2Cl)9.9gを加えて−20℃に冷却
する。三弗化硼素エチルエーテラート5.3gを滴
下した後−20℃で0.5時間撹拌する。反応終了後
ピリジン4.0gを滴下し、反応液を水洗後有機層
を無水硫酸ナトリウムで乾燥する。溶媒を減圧下
留去して得られた粗生成物をメタノールから再結
晶して化合物()(R=−COCH2Cl)16.4gを
得た。(収率80.3%) m.p.244〜246℃ IRνKBr nax1775,1601,1483,1232,1126cm-1 実施例 B 4′−ブロモアセチル−4′−デメチル−エピポド
フイロトキシン−β−D−2,3−ジ−O−ブ
ロモアセチル−4,6−O−エチリデングルコ
シド()(R=−COCH2Br)の製法 (a) 4′−ブロモアセチル−4′−デメチル−エピポ
ドフイロトキシン()(R=−COCH2Br)
の製法 実施例A−(a)において塩化クロロアセチルの代
りに98%塩化ブロモアセチル20.9gを用いて得ら
れた粗生成物をベンゼンから再結晶して化合物
()(R=−COCH2Br)47.0gを得た。(収率
90.2%) m.p.220〜222℃ IRνKBr nax3540,1782,1765,1601,1483,1232,
1124cm-1 (b) 4,6−O−エチリデン−1−O−ベンジル
オキシカルボニル−2,3−ジ−O−ブロモア
セチル−β−D−グルコピラノース()(R
=−COCH2Br)の製法 実施例A−(b)において塩化クロロアセチルの代
りに98%塩化ブロモアセチル53.0gを用いて化合
物()(R=−COCH2Br)76.2gを得た。(収
率87.3%) m.p.140〜142℃ IRνKBr nax1770,1760,1243,1122cm-1 (c) 4,6−O−エチリデン−2,3−ジ−O−
ブロモアセチル−β−D−グルコピラノース
()(R=−COCH2Br)の製法 実施例A−(c)において化合物()(R=−
COCH2Cl)の代りに化合物()(R=−
COCH2Br)58.2gを用いて化合物()(R=−
COCH2Br)44.4gを用い泡状物として得た。(収
率98.9%) IRνCHCl3 nax3575,1758,1275,1125,1095cm-1 (d) 4′−ブロモアセチル−4′−デメチル−エピポ
ドフイロトキシン−β−D−2,3−ジ−O−
ブロモアセチル−4,6−O−エチリデングル
コシド()(R=−COCH2Br)の製法 実施例A−(d)において化合物()(R=−
COCH2Cl)の代りに化合物()(R=−
COCH2Br)13.0gを用い、化合物()(R=−
COCH2Cl)の代りに化合物()(R=−
COCH2Br)12.4gを用いて化合物()(R=−
COCH2Br)18.8gを得た。(収率79.7%) m.p.201〜203℃ IRνKBr nax1770,1763(sh),1603,1483,1232,
1120cm-1 (発明の効果) 本発明の化合物()を用いることにより、化
合物()を高収率で容易に得ることができる。
mp259-262℃, Rf=0.44 Example 2 4'-demethyl-epipodophyllotoxin-β-
Method for producing D-ethylidene glucoside () In Example 1, the reaction was carried out in the same manner as in Example 1 using 4.5 g of pyrrolidine instead of ethylamine, to obtain 4.6 g of compound (). (yield
78.0%) Example 3 4'-demethyl-epipodophyllotoxin-β-
Method for producing D-ethylidene glucoside (2) A reaction was carried out in the same manner as in Example 1 except that 2.0 g of 98% ethylenediamine was used in place of ethylamine to obtain 4.9 g of compound (2). (Yield 83.1%) Example 4 4'-demethyl-epipodophyllotoxin-β-
Method for producing D-ethylidene glucoside () 8.2 g of compound () (R=-COCH 2 Cl) was dissolved in a mixed solvent of 150 ml of chloroform and 50 ml of methanol, 6.6 g of diethylamine was added, and the mixture was stirred at room temperature for 4 hours. After the reaction was completed, the reaction mixture was treated in the same manner as in Example 1 to obtain 3.6 g of compound (). (Yield 61.0%) Example 5 4'-demethyl-epipodophyllotoxin-β-
Method for producing D-ethylidene glucoside () 8.2 g of compound () (R=-COCH 2 Cl) is suspended in 150 ml of methanol, 10 ml of pyridine and 5.0 g of ammonium acetate are added, and the mixture is refluxed for 1 hour. After methanol was distilled off under reduced pressure, the residue was treated in the same manner as in Example 1 to obtain 4.5 g of compound (). (Yield 76.3%) Example 6 4'-demethyl-epipodophyllotoxin-β-
Method for producing D-ethylidene glucoside () Dissolve 8.2 g of compound () (R=-COCH 2 Cl) in a mixed solvent of 150 ml of chloroform and 50 ml of methanol, add 10 ml of triethylamine and 3.5 g of ammonium chloride, and stir at room temperature for 4 hours. . After the reaction was completed, the same treatment as in Example 1 was carried out to obtain the compound ().
4.9g was obtained. (Yield 83.1%) Example 7 4'-demethyl-epipodophyllotoxin-β-
Method for producing D-ethylidene glucoside () In Example 6, the compound () (R=-
4'-bromoacetyl-4'-demethyl-epipodophyllotoxin-β-D-2 instead of COCH 2 Cl),
3-di-O-bromoacetyl-4,6-O-ethylidene glucoside () (R=-COCH 2 Br) 9.5
When the reaction was carried out in the same manner as in Example 6 using g, 4.8 g of compound () was obtained. (Yield 81.8%) Example A 4'-chloroacetyl-4'-demethyl-epipodophyllotoxin-β-D-2,3-di-O-chloroacetyl-4,6-O-ethylidene glucoside ( ) (R=-COCH 2 Cl) (a) Process for producing 4'-chloroacetyl-4'-demethyl-epipodophyllotoxin () (R=-COCH 2 Cl) 4'-demethyl-epipodophyllotoxin Irotoxin ()
40.0 g was suspended in 750 ml of anhydrous ethylene chloride, and 11.9 g of anhydrous pyridine was added thereto, followed by cooling to -20°C.
15.4 g of 95% chloroacetyl chloride was added dropwise to this solution over a period of 1.5 hours, and the mixture was further stirred for 0.5 hour. After the reaction is completed, the reaction solution is washed with water and the organic layer is dried over anhydrous sodium sulfate. The crude product obtained by distilling off the solvent under reduced pressure was recrystallized from methanol to obtain 43.4 g of compound () (R=-COCH 2 Cl). (yield
91.1%) mp238~240℃ IRν KBr nax 3550, 1783, 1765 (sh), 1483, 1230,
1130cm -1 (b) 4,6-O-ethylidene-1-O-benzyloxycarbonyl-2,3-di-O-chloroacetyl-β-D-glucopyranose () (R
=-COCH 2 Cl) 51.0 g of 4,6-O-ethylidene-1-O-benzyloxycarbonyl-β-D-glucopyranose () was suspended in 500 ml of anhydrous chloroform, and 35.6 g of anhydrous pyridine was added. Cool to 0°C. Add 42.8g of 95% chloroacetyl chloride to this solution.
After the dropwise addition over a period of time, the mixture was stirred at room temperature for 0.5 hour. After the reaction is completed, the reaction solution is washed with water and the organic layer is dried over anhydrous sodium sulfate. The crude product obtained by distilling off the solvent under reduced pressure was recrystallized from isopropyl ether to obtain 66.6 g of compound () (R=-COCH 2 Cl). (Yield 90.1%) mp130-131℃ IRν KBr nax 1765, 1255, 1098, 700cm -1 (c) 4,6-O-ethylidene-2,3-diO-
Method for producing chloroacetyl-β-D-glucopyranose () (R=-COCH 2 Cl) 49.3 g of the compound () (R=-COCH 2 Cl) was dissolved in 500 ml of dry acetone, and 10% palladium-carbon was added.
Add 10g and perform hydrogenation at -10 to 15°C under normal pressure. After the reaction is complete, separate the catalyst and add 100ml of dry acetone.
After washing with
35.6 g of -COCH 2 Cl) were obtained as a white foam.
(Yield 99.2%) IRν CHCl3 nax 3600, 1765, 1282, 1130, 1095 cm -1 (d) 4'-chloroacetyl-4'-demethyl-epipodophyllotoxin-β-D-2,3-di- O-
Method for producing chloroacetyl-4,6-O-ethylidene glucoside () (R=-COCH 2 Cl) 11.9 g of compound () (R=-COCH 2 Cl) was dissolved in 150 ml of anhydrous ethylene chloride, and then compound ()
Add 9.9 g (R=-COCH 2 Cl) and cool to -20°C. After 5.3 g of boron trifluoride ethyl etherate was added dropwise, the mixture was stirred at -20°C for 0.5 hour. After the reaction is complete, 4.0 g of pyridine is added dropwise, the reaction solution is washed with water, and the organic layer is dried over anhydrous sodium sulfate. The crude product obtained by distilling off the solvent under reduced pressure was recrystallized from methanol to obtain 16.4 g of compound () (R=-COCH 2 Cl). (Yield 80.3%) mp244-246℃ IRν KBr nax 1775, 1601, 1483, 1232, 1126cm -1 Example B 4'-bromoacetyl-4'-demethyl-epipodophyllotoxin-β-D-2, Process for producing 3-di-O-bromoacetyl-4,6-O-ethylidene glucoside () (R=-COCH 2 Br) (a) 4'-bromoacetyl-4'-demethyl-epipodophyllotoxin () (R= -COCH2Br )
The crude product obtained in Example A-(a) using 20.9 g of 98% bromoacetyl chloride in place of chloroacetyl chloride was recrystallized from benzene to obtain the compound () (R=-COCH 2 Br) 47.0g was obtained. (yield
90.2%) mp220~222℃ IRν KBr nax 3540, 1782, 1765, 1601, 1483, 1232,
1124 cm -1 (b) 4,6-O-ethylidene-1-O-benzyloxycarbonyl-2,3-di-O-bromoacetyl-β-D-glucopyranose () (R
=-COCH 2 Br) Preparation method In Example A-(b), 98% bromoacetyl chloride (53.0 g) was used instead of chloroacetyl chloride to obtain 76.2 g of compound () (R=-COCH 2 Br). (Yield 87.3%) mp140-142℃ IRν KBr nax 1770, 1760, 1243, 1122cm -1 (c) 4,6-O-ethylidene-2,3-di-O-
Process for producing bromoacetyl-β-D-glucopyranose () (R=-COCH 2 Br) In Example A-(c), compound () (R=-
COCH 2 Cl) instead of compound ()(R=-
Compound () (R=-
Obtained as a foam using 44.4 g of COCH 2 Br). (Yield 98.9%) IRν CHCl3 nax 3575, 1758, 1275, 1125, 1095 cm -1 (d) 4'-bromoacetyl-4'-demethyl-epipodophyllotoxin-β-D-2,3-di- O-
Process for producing bromoacetyl-4,6-O-ethylidene glucoside () (R=-COCH 2 Br) In Example A-(d), compound () (R=-
COCH 2 Cl) instead of compound ()(R=-
Using 13.0 g of COCH 2 Br), compound () (R=-
COCH 2 Cl) instead of compound ()(R=-
Compound () (R=-
18.8 g of COCH 2 Br) was obtained. (Yield 79.7%) mp201-203℃ IRν KBr nax 1770, 1763 (sh), 1603, 1483, 1232,
1120cm -1 (Effects of the Invention) By using the compound () of the present invention, the compound () can be easily obtained in high yield.

Claims (1)

【特許請求の範囲】 1 式 〔式中、Rは式−COCH2X(式中Xはハロゲン
を示す)で表わされるハロゲノアセチル基を示
す〕で表わされる4′−ハロゲノアセチル−4′−デ
メチル−エピポドフイロトキシン−β−D−2,
3−ジ−O−ハロゲノアセチル−4,6−O−エ
チリデングルコシド。
[Claims] 1 formula 4'-halogenoacetyl-4'-demethyl-epipodophyllotoxin-β [wherein R represents a halogenoacetyl group represented by the formula -COCH 2 X (wherein X represents a halogen)] -D-2,
3-di-O-halogenoacetyl-4,6-O-ethylidene glucoside.
JP31768789A 1989-12-08 1989-12-08 Acyl derivative of 4'-dimethyl-epipodophyllotoxin-beta-d-ethylidene glucoside Granted JPH02191294A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP31768789A JPH02191294A (en) 1989-12-08 1989-12-08 Acyl derivative of 4'-dimethyl-epipodophyllotoxin-beta-d-ethylidene glucoside

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31768789A JPH02191294A (en) 1989-12-08 1989-12-08 Acyl derivative of 4'-dimethyl-epipodophyllotoxin-beta-d-ethylidene glucoside

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP20618882A Division JPS5998098A (en) 1982-11-26 1982-11-26 Novel method for preparing 4'-demethyl- epipodophyllotoxin-beta-d-ethylidene glucoside and acyl derivative thereof

Publications (2)

Publication Number Publication Date
JPH02191294A JPH02191294A (en) 1990-07-27
JPH032875B2 true JPH032875B2 (en) 1991-01-17

Family

ID=18090905

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31768789A Granted JPH02191294A (en) 1989-12-08 1989-12-08 Acyl derivative of 4'-dimethyl-epipodophyllotoxin-beta-d-ethylidene glucoside

Country Status (1)

Country Link
JP (1) JPH02191294A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2206917T3 (en) * 1997-06-02 2004-05-16 Bristol-Myers Squibb Company ETOPOSIDE PREPARATION PROCEDURE.

Also Published As

Publication number Publication date
JPH02191294A (en) 1990-07-27

Similar Documents

Publication Publication Date Title
KR890000763B1 (en) Precess for producing 4'-demethyl-epipodophyllotoxin-d-ethylidene-glucoside and acyl-derivative thereof
RU2230748C2 (en) Method for preparing clarithromycin as crystals of form ii
EP0180415B1 (en) A 6-0-methylerythromycin A derivative
US4670549A (en) Method for selective methylation of erythromycin a derivatives
CA1239639A (en) Epimeric azahomoerythromycin a derivative and intermediates therefor
JPS6328438B2 (en)
EP0827965B1 (en) Synthesis of 9-deoxo- 9a-aza 11,12-deoxy- 9a-methyl-9a-homoerythromycin A 11,12- hydrogenorthoborate dihydrate
EP1133511B1 (en) Novel intermediates, process for preparing macrolide antibiotic agent therefrom
EP0080819B1 (en) 11-0-alkylerythromycin a derivatives
JPH032875B2 (en)
JPH031317B2 (en)
JPH09309896A (en) Glycosidation of colchicine derivative and its formed product
JPS5896098A (en) Erythromycin a derivative
JPS5849396A (en) 4"-deoxy-14-membered ring macrolide antibiotic substance
JPS5827798B2 (en) Intermediates for new antibacterial agents
JPH023799B2 (en)
JPH051053A (en) New process for producing 6-(3-dimethylamino-propionyl) forskolin
JPS6229595A (en) 5-o-mycaminosyl-narbonolide derivative and production thereof
WO2004007518A1 (en) Erythromycin a 9-o-pseudosaccharinyloxime derivatives and process for the preparation of clarithromycin using the same
JPH0427239B2 (en)
JP2000178294A (en) Production of pentaacetyl-beta-d-glucose
JPS59141596A (en) 3-o-acyl-4"-deoxydesmycosin derivative and its preparation
CA1250284A (en) Antibacterial epimeric azahomoerythromycin a derivative and production thereof
JP3978006B2 (en) Method for producing erythromycin derivative
JPS6018678B2 (en) Method for producing 4-0-(2-amino-2-deoxy-α-D-glucopyranosyl)-2,5-dideoxystreptamine